Webinars and Sponsored Roundtables — Register Now

Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.

Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications. 

Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.

Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Product Spotlight

Roche Diagnostics

cobas e 411

Company

Roche Diagnostics

Name of instrument

cobas e 411

City, State

Indianapolis, IN

Phone

800-428-5074  

Website

https://diagnostics.roche.com/us/en/home.html

Type of instrument

immunoassay

Operational type/Model type

random access, continuous random access/benchtop

List price/First year sold in U.S.

—/2008

Targeted hospital bed size/Targeted

< 100/daily: < 200; monthly: < 40, 000; annual: < 500, 000

Company manufactures instrument

no (manufactured by Hitachi High-Technologies)

Other models in this family of analyzers

No. of units in clinical use in U.S./Outside U.S. (countries)

> 800/> 10, 000 (> 50 countries)

Dimensions (H × W × D)/Instrument footprint

disk: 31.4 × 47.2 × 28.7 in./9.4 sq. ft.;

Weight empty/Weight fully loaded

rack: 31.4 × 67 × 37.4 in./17.4 sq. ft. 

No. of different measured assays onboard simultaneously

disk: 397 lbs./397 lbs.; rack: 551 lbs./551 lbs.

No. of user-definable (open chemistry) channels

18 (18 can be run and calibrated at one time)

Test throughput per hour/Assay run time

0

No. of direct ion-selective electrode channels

86 (86 tests in throughput)/9–27 min. (avg. 18 min.)

Detection methods

• Ion-selective electrode

• Basic metabolic panel

• Complete metabolic panel

Typical time delay from ordering stat test until aspiration of sample

Fully automated microplate immunoassay system

no

Methodologies supported

electrochemiluminescence

Separation methodologies

magnetic particle

Stat time until completion of a ß-hCG test

~10 min. 

Stat time until completion of a cTn test

~10 min.

• Typical time delay from test order to aspiration of sample

< 1 min.

Approximate No. of tests per reagent set/Reagent type

100–200/self-contained multiuse

Reagents refrigerated onboard/Reagents ready to use

no (20ϒ ±3ϒC)/yes

Reagent lot tracking/Reagent inventory

yes/yes

Reagent form/Reagents barcoded

liquid chemistry (closed reagent system)/yes

Separate reagent pack for each specimen/for each test run

no/no

Walkaway capability/Walkaway duration

yes/30–60 min. or 30 specimens (disk), 75 specimens (rack) or 2, 000–3, 000 tests/assays

Design of sample-handling system

disk: ring; rack: rack

Uses washable cuvettes/Uses disposable cuvettes

no/yes (can store up to 360 assay tips, 180 assay cups)

Min.–max. sample volume that can be aspirated at one time 

10–50 µL

Min. reaction volume/Min. specimen volume/Min. dead volume

100 µL/10 µL/100 µL

Dedicated pediatric sample cup

yes (dead volume: 50 µL)

Primary tube sampling

yes

Accommodates most standard tube sizes/Accepts nonstandard tube sizes

yes/yes (12 × 100 mm)

Pierces caps on primary tubes

no

Protects against probe collision

yes

Detects clots/liquid level/short sample

yes/yes/yes

Detection or quantitation for hemolysis, icterus, lipemia, clots

detection for clots; hemolysis, icterus, lipemia not available

Dilutes patient samples onboard/Susceptibility to carryover

yes (can be programmed to perform sample dilutions prior to analysis)/0 (uses disposable tips)

Automatic rerun capability

yes

Sample volume can be concentrated to rerun out-of-linear-range low results

yes

Analyzer requires dedicated water supply

no (3 L consumption for 250 tests)

Autocalibration/Multipoint calibration supported

yes (calibrants are not stored onboard)/yes (recommended avg. frequency: 28 days)

Typical calibration frequency for ISE/therapeutic drugs/drugs of abuse/general chemistries/immunoassays

—/—/—/—/28 days

Automatic programmable start/Automatic programmable shutdown

yes (4 min. avg. start-up time)/yes

Onboard real-time QC/Onboard software capability to review QC

yes/yes

Supports multiple QC lot numbers per analyte

yes

Waste management

automated collection onboard instrument

Sample barcode-reading capability/Autodiscrimination

yes (Interleaved 2 of 5, Codabar, Code 39, Code 128, PDF417)/yes

Lab can control analyzer from remote computer

no

Instrument can diagnose its own malfunctions

yes (operator intervention required to order parts)

System malfunctions can be diagnosed via remote monitoring

yes

UPS backup power supply

yes

Data-management capability/LIS or EHR systems interfaced

onboard/SCC Soft Computer, Meditech, Cerner, Epic, Sunquest, more

LIS interface provided/Bidirectional interface capability

yes (included in instrument price)/yes (broadcast download and host query)

Modem servicing provided/Service engineer on-site response time

yes/< 24 hrs.

Mean time between failures

368 days (displays error codes for troubleshooting)

Average scheduled maintenance time by lab personnel

daily: 5 min.; weekly: 6 min.; monthly: 11 min.

Maintenance records kept onboard for user/vendor

yes (includes audit trail of who replaced parts)/yes (includes audit trail of who replaced parts)

Maintenance training demonstration module onboard

yes

Training included with purchase/Avg. time for basic user training

yes (1 training slot)/1 week (at both vendor and customer sites)

Advanced operator training/Extra charge for follow-up or advanced training

yes (at vendor site)/yes

Warranty provided/Cost of annual service contract (24 h/7 d)

yes (1 year)/configuration dependent

Distinguishing features (supplied by company)

drives lab efficiency with standardized instrumentation, reference ranges, consumables, and usage; minimizes downtime with industry-leading engineering and service; 325-day mean time between repair visits (average); speeds up turnaround time for high-volume stat assays

More products
in this guide

DxC 500 AU Clinical Chemistry Analyzer
DxC 500i Clinical Analyzer
Pictus 500 (P500)
DS2 Automated ELISA System
Stat Profile Prime Plus
Vitros XT 3400 Chemistry Systems
cobas pure integrated solutions
B⋅R⋅A⋅H⋅M⋅S KRYPTOR compact PLUS